Skip to main content
SpringerLink
Log in

CD154/CD40-Interaktion

Kostimulationsblockade zur Abstoßungsprophylaxe

Interaction between CD154 and CD40

Blocking of co-stimulation for prevention of rejection

  • Nephro molekular
  • Published:
Der Nephrologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Chen L, Flies DB (2013) Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 13(4):227–242. doi:10.1038/nri3405

    Article  PubMed  PubMed Central  Google Scholar 

  2. Zhai Y, Kupiec-Weglinski JW (2004) The CD154-CD40 costimulation pathway in organ transplantation. Transplant Rev 18(1):10–19. doi:10.1016/j.trre.2003.12.001

    Article  Google Scholar 

  3. Zhang T, Pierson RN, Azimzadeh AM (2015) Update on CD40 and CD154 blockade in transplant models. Immunotherapy 7(8):899–911. doi:10.2217/IMT.15.54

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Larsen CP, Elwood ET, Alexander DZ et al (1996) Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381(6581):434–438. doi:10.1038/381434a0

    Article  CAS  PubMed  Google Scholar 

  5. Trambley J, Bingaman AW, Lin A et al (1999) Asialo GM1+ CD8+ T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 104(12):1715–1722. doi:10.1172/JCI8082

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ford ML, Larsen CP (2009) Translating costimulation blockade to the clinic: lessons learned from three pathways. Immunol Rev 229(1):294–306. doi:10.1111/j.1600-065X.2009.00776.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kawai T, Andrews D, Colvin RB, Sachs DH, Cosimi AB (2000) Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 6(2):114–114. doi:10.1038/72162

    Article  CAS  Google Scholar 

  8. Pearson TC, Trambley J, Odom K et al (2002) Anti-CD40 therapy extends renal allograft survival in rhesus macaques. Transplantation 74(7):933–940. doi:10.1097/01.TP.0000020751.87264.61

    Article  CAS  PubMed  Google Scholar 

  9. Rush J, Wieczorek G, Audet M, Schneider M, Espie P, Roth L, Heusser C, Bruns C, Patel D, Cordoba F (2015) A novel, blocking anti-CD40 monoclonal antibody prolongs non-human primate renal allograft survival in the absence of B‑cell depletion or thromboembolic events [abstract]. Am J Transplant 15:2825–2836

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Nephrologie, Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Deutschland

    B. Wilde

Authors
  1. M. Cherneha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Wilde
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Wilde.

Ethics declarations

Interessenkonflikt

M. Cherneha und B. Wilde geben an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

O. Witzke, Essen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cherneha, M., Wilde, B. CD154/CD40-Interaktion. Nephrologe 12, 360–362 (2017). https://doi.org/10.1007/s11560-017-0180-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11560-017-0180-8

Search

Navigation